Article
A randomised controlled trial of short term growth and collagen
turnover in asthmatics treated with inhaled formoterol and budesonide
Carsten Heucka, Lene Heickendorffb, Ole D Wolthersc
a Department of
Paediatrics, Skejby Sygehus, Aarhus University Hospital, Aarhus,
Denmark, b Department of Clinical
Biochemistry, Aarhus Amtssygehus, Aarhus University Hospital, c Department of Paediatrics, Randers
Hospital, Randers, DK-8900 Randers, Denmark
Correspondence to: Dr Wolthers email: o.d.wolthers{at}dadlnet.dk
Accepted 4 May 2000
AIMS
To determine effects on short
term growth and collagen turnover of adding formoterol (Eformoterol) to
half the glucocorticoid dose in children with asthma, treated with
inhaled budesonide (Pulmicort Turbuhaler).
DESIGN
A randomised double blind,
placebo controlled crossover study with two six-week periods.
SETTING
Outpatient clinic in
secondary referral centre.
SUBJECTS
A total of 27 prepubertal
children aged 6-13 years.
INTERVENTIONS
Formoterol 12 µg
and dry powder budesonide 100 µg twice daily in one period; placebo
and dry powder budesonide 200 µg twice daily in the other.
OUTCOME MEASURES
Primary outcome
measures were lower leg growth rate, and serum and urine markers of
type I and type III collagen turnover. Secondary outcome measures were
inflammation markers in serum, and parameters of asthma control.
RESULTS
During budesonide 200 µg
twice daily treatment, mean lower leg growth rate was 0.14 mm/week
(p = 0.02) lower than during the formoterol and budesonide period.
Similar statistically significant effects on markers of collagen
turnover were found, whereas inflammation markers and asthma control
did not vary statistically significantly between the two periods.
CONCLUSIONS
In children treated
with inhaled glucocorticoids, halving the dose and adding formoterol is
associated with faster short term growth and an increase in markers of
collagen turnover, with no loss of asthma control.
Keywords: asthma; growth; inhaled glucocorticoids; formoterol; collagen turnover; bronchial inflammation
© 2000 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Sindi, A., Todd, D. C., Nair, P.
(2009). Antiinflammatory Effects of Long-Acting {beta}2-Agonists in Patients With Asthma: A Systematic Review and Metaanalysis. Chest
136: 145-154
[Abstract] [Full Text] -
Lopez, F. J., Ardecky, R. J., Bebo, B., Benbatoul, K., De Grandpre, L., Liu, S., Leibowitz, M. D., Marschke, K., Rosen, J., Rungta, D., Viveros, H. O., Yen, W.-C., Zhi, L., Negro-Vilar, A., Miner, J. N.
(2008). LGD-5552, an Antiinflammatory Glucocorticoid Receptor Ligand with Reduced Side Effects, in Vivo. Endocrinology
149: 2080-2089
[Abstract] [Full Text] -
Priftis, K. N., Papadimitriou, A., Gatsopoulou, E., Yiallouros, P. K., Fretzayas, A., Nicolaidou, P.
(2006). The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Respir J
27: 316-320
[Abstract] [Full Text] -
Rosen, J., Miner, J. N.
(2005). The Search for Safer Glucocorticoid Receptor Ligands. Endocr. Rev.
26: 452-464
[Abstract] [Full Text] -
Russell, G
(2004). The use of inhaled corticosteroids during childhood: plus ca change.... Arch. Dis. Child.
89: 893-895
[Full Text] -
Barnes, P.J.
(2002). Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids. Eur Respir J
19: 182-191
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



